Alkacel (Melphalan) — Patient Information (UK)

Alkacel is a brand of the chemotherapy medicine melphalan. It is used to treat certain cancers, typically in hospital or specialist cancer-care settings. This page explains how Alkacel works, how it is used, key safety points, and practical guidance for people in the United Kingdom.

Important: If you have questions about your specific treatment plan—such as timing of doses, supportive medicines, or monitoring schedules—please speak with your oncology team.

Basic product information

• Medicine name: Alkacel
• Active ingredient: Melphalan
• Medicine type: Cytotoxic chemotherapy (alkylating agent)
• Medicinal form(s): Alkacel is typically supplied for use by specialist services (the exact presentation and route may vary by local product availability and regimen).
• Where it is used: UK cancer centres and specialist services

How to take/use: Depending on the regimen, melphalan may be given by a healthcare professional as part of treatment protocols. Your care team will provide specific instructions for your situation.

How Alkacel works (mechanism of action)

Melphalan belongs to a group of chemotherapy drugs called alkylating agents. It works by damaging the DNA inside cancer cells.

• Melphalan “alkylates” DNA, which interferes with DNA replication.
• This leads to cell death, especially in rapidly dividing cancer cells.
• Because it can also affect healthy rapidly dividing cells (e.g., bone marrow), it can cause side effects such as low blood counts.

Different cancer types may respond differently, and doctors choose regimens based on the disease, stage, and overall health of the patient.

What Alkacel is used for (typical use & indications)

In the UK, melphalan is used in particular cancer settings. Common indications (as used in clinical practice and supported by licensed use) include:

• Multiple myeloma (a cancer of plasma cells)
• Ovarian cancer and other selected solid tumours in specialist settings, depending on local protocols
• Sometimes as part of conditioning regimens before stem cell transplantation (where used, it is administered within a specialist transplant protocol)

Note: The exact indication and regimen depend on the product formulation, route, and your overall clinical plan.

When Alkacel is given (timing & treatment schedules)

Melphalan is usually administered as a planned cycle—for example, in days grouped together, followed by a rest period—depending on the condition being treated.

• Typical cycle structure: Your team will schedule specific days/times for dosing.
• Monitoring between cycles: Blood tests are often performed to check blood counts and organ function.
• Supportive treatment: You may receive additional medicines to reduce side effects (e.g., anti-sickness treatment).

Practical tip: Keep a written record of cycle dates and blood test days. If you miss a scheduled attendance or dose, contact your oncology team promptly for advice.

Food interactions

Because Alkacel/melphalan is often administered under clinical supervision and dosing routes vary by regimen, food effects may differ. In general:

• Do not take extra doses to “catch up” if you have missed advice around food.
• If your regimen includes an oral component (depending on your specific protocol), the oncology team will tell you whether to take it with or without food.
• If you experience nausea, ask about anti-sickness medicines and dietary strategies (small meals, bland foods).

Always follow your individual instructions provided by your care team or pharmacist.

Alcohol and medicine interactions

Alcohol is not usually recommended during chemotherapy because it may worsen side effects (such as nausea, fatigue, and dehydration) and can affect liver function. Melphalan is processed by the body in a way that may not be directly “cancelled out” by alcohol, but alcohol can still increase risks.

• Avoid alcohol during treatment unless your doctor says otherwise.
• If you drink alcohol, discuss your plan with your oncology team, especially if you have liver or kidney issues.
• Be cautious with other medicines that can affect blood counts or bleeding risk.

Medicine interactions: Melphalan may interact with other treatments used for cancer or supportive care. Examples of medicines where you should seek advice include:

• Other chemotherapy agents or treatments that suppress the immune system
• Vaccines (especially live vaccines)
• Medicines that increase infection risk or affect bone marrow
• Medicines for gout or uric acid (because chemotherapy can increase uric acid levels)
• Strong inhibitors/inducers of drug metabolism pathways (your pharmacist can assess this for your exact regimen)

Action: Provide your full medication list to your pharmacist/oncology team (including over-the-counter products and herbal remedies).

Pharmacokinetics (how the body handles melphalan)

Pharmacokinetics describe how a medicine is absorbed, distributed, metabolised, and eliminated. For melphalan, the exact profile can vary with route and regimen.

• Absorption: Depends on route (melphalan may be administered in specialist protocols).
• Distribution: Melphalan distributes throughout the body and can reach tissues where cancer cells are present.
• Metabolism: It is metabolised primarily in the body via chemical conversion processes that reduce its activity and change how it is cleared.
• Elimination: The medication and its metabolites are eliminated mainly through kidneys and to some degree through other pathways. Kidney function can therefore influence exposure.
• Half-life: The time taken for plasma levels to reduce by half can vary by patient and regimen.

Why this matters: Because melphalan exposure can be influenced by organ function and treatment plan, your medical team may adjust dosing and closely monitor blood counts, kidney function, and other safety markers.

Dosing and administration

How dosing is determined: Melphalan dosing is individualised based on factors such as:

• Diagnosis and treatment goal
• Whether the medicine is part of a standard chemotherapy cycle or transplant conditioning
• Body surface area (BSA) or body weight (depending on protocol)
• Blood counts and organ function (particularly kidneys and bone marrow reserve)
• Prior treatment history

Typical dose patterns: Melphalan regimens can include several consecutive days of treatment followed by recovery periods, or other schedules depending on the protocol.

Administration: Your oncology team will administer melphalan according to the regimen and safety procedures for cytotoxic medicines.

Safety profile and side effects

Like other chemotherapy drugs, melphalan can cause side effects. Some effects are common and manageable, while others require urgent medical attention.

Common side effects

• Low blood counts (neutropenia, anaemia, thrombocytopenia), which can increase infection risk or cause bruising/bleeding
• Nausea and vomiting
• Loss of appetite
• Fatigue
• Hair thinning (may vary by regimen)
• Diarrhoea or constipation
• Mouth sores (mucositis)
• Skin changes (sensitivity, rash) in some cases

Serious side effects — get urgent help

Seek urgent medical advice (e.g., contact your oncology team immediately or use NHS 111 / emergency services as appropriate) if you develop:

• Fever (often defined clinically as a temperature of 38°C or higher) especially during periods of low white cells
• Signs of infection: chills, feeling very unwell, shortness of breath, persistent cough
• Unusual bleeding: nosebleeds that won’t stop, bleeding gums, blood in urine/stool, widespread bruising
• Severe allergic-type reactions: swelling of face/lips, wheezing, severe rash
• Severe dehydration from persistent vomiting/diarrhoea

Long-term risks (discuss with your specialist)

• Possible impacts on fertility (discuss fertility preservation options before treatment)
• Potential risk of secondary cancers in long-term survivors (risk depends on treatment history and other factors)
• Effects related to repeated chemotherapy cycles

Practical use tips (patient-friendly guidance)

Before starting each cycle

• Attend scheduled blood tests and clinic visits.
• Tell your team about recent infections, fevers, or new symptoms.
• Review your medication list, including:
  • tablets, creams, supplements
  • over-the-counter remedies
  • herbal products

During treatment

• Hydration: Staying adequately hydrated can help reduce complications, but follow any fluid advice you’ve been given—especially if you have heart or kidney conditions.
• Oral care: Use a soft toothbrush and gentle mouth rinses as advised. Report mouth sores early.
• Food and nausea: Choose small frequent meals. Ask your team about anti-sickness medicines.
• Infection prevention: Practice good hand hygiene and avoid close contact with people who are unwell.
• Bleeding precautions: Use a soft toothbrush; avoid activities that can cause injury if platelet counts are low.

After treatment

• Attend follow-up appointments and repeat tests.
• Report delayed symptoms such as unusual bruising, persistent infections, or ongoing fatigue.
• Discuss vaccination plans with your oncology team (timing and type of vaccines matter after chemotherapy).

Alternative options

“Alternative options” depend strongly on the cancer type, stage, and previous treatments. Your oncology team may consider chemotherapy alternatives, targeted therapies, immunotherapies, or transplant-related protocols (in appropriate cases).

Examples of alternatives that may be considered for multiple myeloma depending on the regimen include combinations involving medicines such as proteasome inhibitors, immunomodulatory agents, and monoclonal antibodies. For other cancers, different chemotherapy drugs may be used.

• Chemotherapy alternatives: Other cytotoxic agents may be used in similar or different combinations.
• Regimen changes: If side effects are difficult to manage, doctors may adjust doses or switch to another protocol.
• Supportive care optimisation: Even when the core anti-cancer medicine is unchanged, supportive medicines (anti-sickness, growth factors for blood counts, infection prevention strategies) can improve tolerability.

Discuss options with your specialist to understand why melphalan is recommended for your case and what other choices could be appropriate.

UK market and legal context (what to expect in the UK)

In the United Kingdom, chemotherapy medicines are regulated under the medicines and healthcare framework and are supplied through appropriate channels. Cancer treatment is delivered through NHS and private specialist providers, with governance around:

• Specialist prescribing and administration: Cytotoxic medicines typically require specialist handling and administration procedures.
• Patient monitoring: Routine blood tests and safety assessments are standard.
• Pharmacovigilance: Medicines are monitored for safety throughout their use in the population.

Supply and availability can vary by brand, formulation, and procurement routes. Your clinical team will guide the safest and most suitable option for your treatment plan.

Recent guidance and monitoring (general UK approach)

Cancer care guidance in the UK evolves over time based on clinical trial results and safety monitoring. While your oncology team follows the most current protocols, common themes include:

• Strict infection monitoring: Prompt action if fever or infection is suspected during chemotherapy-related low white cell periods.
• Blood count monitoring: Ongoing assessment of neutrophils, platelets, and haemoglobin.
• Supportive care: Use of anti-sickness medicines and preventive strategies where appropriate.
• Medication reconciliation: Careful checks to avoid drug interactions and duplicate therapies.

If you want the latest official information, ask your healthcare provider or check trusted NHS cancer resources and guidance from professional organisations.

Delivery and availability (UK online pharmacy information)

Availability of Alkacel/melphalan products can vary. In the UK, cytotoxic chemotherapy medicines are typically supplied under controlled arrangements, and not all online purchases are suitable for direct home administration.

• Delivery arrangements: Your oncology service may arrange supply directly to the hospital or clinic for administration.
• Stock status: If supply is temporarily unavailable, your pharmacy may source an alternative brand or adjust timing according to clinical urgency.
• Verification: Pharmacies may carry out checks to ensure the correct medicine and regimen details.

For the best outcome: If you are ordering through an online pharmacy, ensure all information required for dispensing is accurate and that you understand where and how the medicine will be delivered for your treatment pathway.

FAQ — Frequently asked questions

Is Alkacel the same as melphalan?

Yes. Alkacel is a brand name that contains melphalan as the active ingredient.

What is the main effect of melphalan?

Melphalan damages DNA in cancer cells (alkylating action), which helps stop cancer cell growth and can lead to cell death.

How long does treatment take?

Melphalan is usually given in cycles. Each person’s schedule is different depending on diagnosis, regimen, and blood count recovery. Your team will provide specific dates and intervals.

Can I take Alkacel with food?

Food instructions can depend on the specific formulation and regimen. If you have oral instructions, follow your oncology team’s guidance. If you receive it under healthcare supervision, your team will advise around meals if needed for side effects such as nausea.

What should I do if I feel sick after treatment?

Contact your oncology team if symptoms are severe or not controlled. If you have repeated vomiting/diarrhoea, signs of dehydration, fever, or you feel suddenly worse, seek urgent medical advice.

When should I worry about infection?

During chemotherapy, fever can be an emergency. If you have a temperature of 38°C or higher or feel unwell with infection-like symptoms, contact your cancer team immediately or use urgent NHS advice.

Can I drink alcohol during treatment?

It’s generally best to avoid alcohol during chemotherapy because it may worsen side effects and dehydration and may affect how you tolerate treatment. Ask your oncology team if you want personalised advice.

Are there medicines or vaccines I should avoid?

Some medicines can increase risks with chemotherapy, and some vaccines—particularly live vaccines—may not be suitable during and soon after treatment. Check with your pharmacist or oncology team before taking new medicines or vaccines.

What happens if my blood counts are low?

Your team may delay the next cycle, reduce doses, or add supportive treatments (such as medications that help the body produce blood cells), depending on your blood test results and symptoms.

What are the practical steps to reduce side effects?

Common helpful steps include:

• attending blood tests and appointments
• taking prescribed anti-sickness medicine as directed
• maintaining hydration if allowed
• practising good hygiene to reduce infection risk
• reporting fever, bleeding, or infection symptoms promptly

Where can I find reliable UK support during cancer treatment?

You can speak with your cancer specialist nurse, your GP, NHS 111 for urgent advice, and trusted NHS cancer information services. Your oncology team can also advise on local support groups.

Disclaimer: This information is for general patient education and does not replace advice from your healthcare team. Your dose, regimen, monitoring plan, and supportive care may differ based on your individual circumstances.